The government funding proposal put forth by President Biden simultaneously contains both positive and negative aspects when it comes to marijuana policy reform efforts in the appropriations realm.
Last week, White House Press Secretary Jen Psaki reiterated the President’s position that cannabis should be rescheduled under federal law to Schedule II rather than descheduled from the Controlled Substances Act… Tonight, President Biden will be delivering his first major address to Congress and to the American people to discuss his vision and priorities for the rest of his first presidential term.
“It is impractical at best and disingenuous at worst for the Biden campaign to claim that rescheduling cannabis from Schedule I to Schedule II – the same category as cocaine– would in any way address the existing inconsistencies between state and federal marijuana laws”
This week, a letter led by Representatives Earl Blumenauer, Don Beyer, Jared Huffman, Mondaire Jones, Barabara Lee, and cosigned by 25 other members, called on the Biden Administration to “…act within its power to stop legitimizing unfair cannabis laws.”
In the recently published questions for the record (QFRs) to Judge Merrick Garland from members…
The revisions make it clear that the federal Drug-Free Workplace Act — passed in 1988 — remains in place, and that federal employees “are required to refrain” from the use of either cannabis or other federally controlled substances “whether on or off duty.” Employees who do not do so will face disciplinary action.